Functional Evaluation of Two Infant Formula Supplemented With Probiotics Isolated From Breast Milk

June 28, 2017 updated by: Biosearch S.A.
A randomized double blinded controlled study including infants at the age of 1 month . Infants are assigned randomly to either infant formula supplemented with B. breve CECT7263 or L.fermentum CECT5716 (Probiotic groups), or the same formula without the probiotic strain (Control group). The primary outcome of the study is the body weight gain of infants. Secondary outcomes are incidence of infections, symptoms related with intestinal function, and fecal microbiota

Study Overview

Study Type

Interventional

Enrollment (Actual)

236

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Córdoba, Spain, 14004
        • Hospital Reina Sofia
      • Granada, Spain, 10012
        • Servicio Andaluz de Salud

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

3 weeks to 1 month (Child)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Newborn infants at term (37-42 weeks gestational age) healthy during the first month of life, for reasons unrelated to the study, abandon breastfeeding during the first month of life.
  • Signature of informed parental or guardian consent.

Exclusion Criteria:

  • Allergic to the protein in cow's milk.
  • Lactose intolerant.
  • Suffering from a serious metabolic disease.
  • They have experienced or are experiencing some severe gastrointestinal disease.
  • Receive some form of chronic medication or are receiving antibiotics at the time of capture.
  • Low expectation of compliance with the study protocol.
  • allergic to any group of antibiotics.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Quadruple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Bifido
Infant formula containing Bifidobacterium breve CECT7263
Probiotic bacteria originally isolated from breast milk: the strain Bifidobacterium breve CECT7263
Active Comparator: Lfer
Infant formula containing Lactobacillus fermentum CECT5716
Probiotic bacteria originally isolated from breast milk: the strain Lactobacillus fermentum CECT5716
Placebo Comparator: Control
Standard infant formula
Standard infant formula

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Body weight gain
Time Frame: 12 months versus baseline
Body weight gain at 12 months (grams)
12 months versus baseline

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Length
Time Frame: 1,2,4,6,9 and 12 months of age
Length (cm)
1,2,4,6,9 and 12 months of age
Body weight
Time Frame: 1,2,4,6,9 and 12 months of age
Body weight of infants at different times (kg)
1,2,4,6,9 and 12 months of age
Incidence of infections
Time Frame: total incidence during intervention (11 months)
Events of infections diseases during intervention period (Incidence rate)
total incidence during intervention (11 months)
Bacterial load in feces
Time Frame: 1,2,4,6,9 and 12 months of age
Counts of Lactobacillus, bifidobacteria, bacteroides, clostridium (CFU/g feces)
1,2,4,6,9 and 12 months of age
Regurgitation
Time Frame: each 2 weeks until 6 months of age and monthly until 12 months of age
Measurement by score: 1 = not at all, 2 = regurgitation of small amounts during or shortly after feeding, 3 = larger regurgitation during or shortly after feeding, 4 = minor vomiting with time-lag to prior feeding, and 5 = severe vomiting with considerable loss of fluid.
each 2 weeks until 6 months of age and monthly until 12 months of age
Fecal deposition
Time Frame: each 2 weeks until 6 months of age and monthly until 12 months of age
Measurement by score:1 = <1 time, 2 = 1-3, 3 = 4-6, 4 = 7-10, and 5 = >10.
each 2 weeks until 6 months of age and monthly until 12 months of age
Infant colic
Time Frame: each 2 weeks until 6 months of age and monthly until 12 months of age
Average crying hours per day during the last two days of each period of measurement which is each 2 weeks until 6 months of age and monthly until 12 months of age. Score: no crying; < 3 hours/day; 3-6 hours/day; 6-12 hours/day; > 12 hours/day
each 2 weeks until 6 months of age and monthly until 12 months of age
Flatulency
Time Frame: each 2 weeks until 6 months of age and monthly until 12 months of age
Average of duration of flatulence episodes (hours per day) during the last two days of each period of measurement which is each 2 weeks until 6 months of age and monthly until 12 months of age.Measurement by the score:no flatulency; < 3 hours/day; 3-6 hours/day; 6-12 hours/day; > 12 hours/day
each 2 weeks until 6 months of age and monthly until 12 months of age
Hours of night sleep
Time Frame: each 2 weeks until 6 months of age and monthly until 12 months of age
Average of time of night sleep (hours per day) during the last two days of each period of measurement which is each 2 weeks until 6 months of age and monthly until 12 months of age.Measurement by the score: < 4 hours ; 4-6 hours; 6-9 hours; 9-12 hours; > 12 hours
each 2 weeks until 6 months of age and monthly until 12 months of age
Total hours of sleep/day
Time Frame: each 2 weeks until 6 months of age and monthly until 12 months of age
Average of total time of sleep (hours per day) during the last two days of each period of measurement which is each 2 weeks until 6 months of age and monthly until 12 months of age.Measurement by the score: < 11 hours;  11-14 hours; 14-17 hours; 17-20 hours;  > 20 hours
each 2 weeks until 6 months of age and monthly until 12 months of age

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2011

Primary Completion (Actual)

November 1, 2014

Study Completion (Actual)

December 1, 2015

Study Registration Dates

First Submitted

August 11, 2016

First Submitted That Met QC Criteria

June 28, 2017

First Posted (Actual)

July 2, 2017

Study Record Updates

Last Update Posted (Actual)

July 2, 2017

Last Update Submitted That Met QC Criteria

June 28, 2017

Last Verified

August 1, 2016

More Information

Terms related to this study

Other Study ID Numbers

  • P024

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Infant Nutrition

Clinical Trials on Bifido

Subscribe